• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Horizons in Cancer Research: Volume 45

Horizons in Cancer Research: Volume 45

9781612093772
774.84 zł
697.35 zł Save 77.49 zł Tax included
Lowest price within 30 days before promotion: 697.35 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Horizons in Cancer Research presents original research results on the leading edge of cancer. Topics discussed include paclitaxel in chemotherapy and neurotoxicity; the role of prostate-specific antigen (PSA) in pathological angiogenesis and prostate tumour growth; second primary cancer in children and adults; CD133 as a cancer stem cell marker; psychosocial oncology; brain metastases and target therapy for DSB repair deficient tumours; and management of recurrent cervical carcinoma.
Product Details
73192
9781612093772
9781612093772

Data sheet

Publication date
2011
Issue number
1
Cover
hard cover
Pages count
306
Dimensions (mm)
260.00 x 180.00
Weight (g)
802
  • Preface; Paclitaxel:: Chemotherapy & Neurotoxicity-The Two Sides of the Coin; Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis & Prostate Tumor Growth; Proteomics in the Discovery of Biomarkers of Chemoresistance:: The Current Status of Paclitaxel Resistance in Human Epithelial Ovarian Cancer; Macromolecules as Paclitaxel Carriers:: From Chemical Considerations to Clinical Applications; Paclitaxel Crystals:: Molecular Interactions, Nucleation & Growth, & Possible Implications on Cell Studies; Second Primary Cancer in Children & Adults:: A Comparison; Critical Evaluation of the Use of CD133 as a Cancer Stem Cell Marker in Solid Tumors; Psychosocial Oncology; Brain Metastases:: Symptoms, Diagnosis & Treatment; Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer.
Comments (0)